x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Category: Real World Evidence

    Marksman Healthcare > Blog > Real World Evidence

11Aug

Generating Clinical Evidence From Electronic Health Records and Patient Registries

by MarksMan Healthcare,  0 Comments

Both electronic health records (EHRs) and patient registries store and use patient-related clinical information. However, they are conceptualized for different purposes. Both are a significant source of real-world evidence (RWE) […]

Read More

25Jul

Comparative Effectiveness in Real-World Settings through Pragmatic Clinical Trials

by MarksMan Healthcare,  0 Comments

Randomized controlled trials (RCTs) are the mainstay of clinical research; it is estimated that about 18,000 RCTs are published each year. However, traditional RCTs usually take a long time to […]

Read More

21Jul

RWE Framework by NICE (UK) for Optimizing RWD Collection and RWE Generation

by MarksMan Healthcare,  0 Comments

Evidence from randomized clinical trials (RCTs) continues to be the standard reference point for treatment efficacy across the world. However, RCTs enrol patients based on strict inclusion and exclusion criteria, […]

Read More

27Jun

The Expanding Role of Real-World Evidence in Evaluation of Medical Devices

by MarksMan Healthcare,  0 Comments

Concerns about the consistency of the post-marketing surveillance (PMS) for safety of medical devices is well known across the world. Only around 13% of post-marketing surveillance (PMS) clinical studies are […]

Read More

31May

Tokenization in Real World Evidence Studies: the Concept and its Advantages

by MarksMan Healthcare,  0 Comments

With all stakeholders increasingly realising the value real-world evidence (RWE) studies can bring into the healthcare delivery, newer applications of RWE are being discovered with each passing day. RWE has […]

Read More

28May

Federated Data Networks (FDNs): Enhancing the Quality of RWE Research

by MarksMan Healthcare,  0 Comments

Real-World Data (RWD), from which Real-World Evidence (RWE) is generated, has the unique capability of depicting real-world outcomes. RWD can also reduce timelines for research and development, and generate profound […]

Read More

25May

How to Improve Transparency with Real World Data to Support Market Access?

by MarksMan Healthcare,  0 Comments

The USFDA defines real-world data (RWD) as ‘the data relating to patient health status and/or the healthcare delivery that is routinely collected from a variety of sources’, and real-world evidence […]

Read More

06May

The Role of Real World Evidence in Optimizing the Conduct of Clinical Trials

by MarksMan Healthcare,  0 Comments

Real-world evidence (RWE) is derived from real-world data (RWD) sources, such as electronic health records (EHRs), claims data, data from product/disease registries, pharmacy data, social media, and pragmatic trials. RWE […]

Read More

27Apr

How to Prepare Real World Evidence for Regulatory Approval?

by MarksMan Healthcare,  0 Comments

Drug makers usually put in rigorous efforts to fast-track and reduce the cost burden of regulatory decision-making by regulatory authorities like USFDA and EMA. As a part of these efforts, […]

Read More

Posts navigation

1 2 3

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Collaborative Approach in Conducting Systematic Literature Reviews For Evidence Synthesis

June 5, 2023

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Collaborative Approach in Conducting Systematic Literature Reviews For Evidence Synthesis

June 5, 2023

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...